Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

2(40.0%)

5Total

N/A(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06018363Phase 1Recruiting

Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection

Role: lead

NCT06841822Not ApplicableRecruiting

The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament on Hemodynamics During the Induction Phase of Thoracoscopic Lung Lobectomy: A Multicenter, Double-Blind, Randomized Controlled Trial

Role: collaborator

NCT06147505Phase 1Suspended

XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)

Role: lead

NCT06249373Not ApplicableRecruiting

The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF

Role: collaborator

NCT05526339Not ApplicableUnknown

HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients

Role: collaborator

All 5 trials loaded